Advertisement

Topics

Oxford Therapeutics Consulting Limited Company Profile

23:16 EST 19th February 2018 | BioPortfolio

Consulting for the phatmaceutical and drug development.

Location

The Magdalen Centre
Oxford
Oxfordshire
OX4 4GA
United Kingdom

Contact

Phone: +44 1865 784874
Fax: +44 1865 784875
Email: jansteiner@oxrx.xom


News Articles [1121 Associated News Articles listed on BioPortfolio]

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Oxford Firm Recruits Two Partners to Build Drug Discovery AI

e-Therapeutics has teamed up with AI experts Intellegens and Biorelate to improve its technology for computer-based drug discovery.  Based in Oxford, e-Therapeutics has the mission of reducing the ti...

Oxford Biotech Makes a Latin American Deal for Its Antibiotic

In a deal worth up to €23.6M, Summit Therapeutics licensed the commercialization of its new antibiotic ridinilazole to Eurofarma. Oxford-based Summit Therapeutics is working on new antibiotics to fi...

Oxford mothers-to-be learn about gestational diabetes research

Oxford researchers have attended two events in Oxford to let pregnant women know how to have a healthy pregnancy and to ask them to get involved in giving their views on future research. The researche...

Oxford Centre for Haematology launched

The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxfor...

Nightstar gets rights to preclinical ophthalmic program from Oxford University Innovation

Oxford University Innovation Ltd. licensed Nightstar Therapeutics Ltd. exclusive worldwide rights to a preclinical gene therapy for treating Stargardt disease.

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...

Adaptimmune Therapeutics plc: Adaptimmune marks Official Opening of U.K. Headquarters

Flagship Facility is new Base for U.K. Research and Development OperationsPHILADELPHIA and OXFORD, U.K., 2017-11-06 14:14 CET (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leade...

Clinical Trials [250 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [2405 Associated Companies listed on BioPortfolio]

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Oxford Therapeutics Consulting Limited

Consulting for the phatmaceutical and drug development.

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Isis Innovation

Isis Innovation is the technology transfer company of the University of Oxford, commercialising the research generated by University researchers and owned by the University.Isis Innovation Ltd is a wh...

Accelrys, Inc

The software businesses of the Oxford Molecular Group were incorporated into Accelrys Inc. on June 1, 2001.Oxford Molecular was a leading provider of cheminformatics tools. Founded in 1989, Oxford Mol...

More Information about "Oxford Therapeutics Consulting Limited" on BioPortfolio

We have published hundreds of Oxford Therapeutics Consulting Limited news stories on BioPortfolio along with dozens of Oxford Therapeutics Consulting Limited Clinical Trials and PubMed Articles about Oxford Therapeutics Consulting Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Therapeutics Consulting Limited Companies in our database. You can also find out about relevant Oxford Therapeutics Consulting Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record